SugarBud Craft Growers Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
SugarBud Craft Growers's earnings have been declining at an average annual rate of -25.6%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 31.1% per year.
Anahtar bilgiler
-25.6%
Kazanç büyüme oranı
-3.4%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 23.1% |
| Gelir büyüme oranı | 31.1% |
| Özkaynak getirisi | -157.9% |
| Net Marj | -405.8% |
| Son Kazanç Güncellemesi | 30 Jun 2022 |
Gelir ve Gider Dağılımı
SugarBud Craft Growers nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 22 | 2 | -9 | 5 | 0 |
| 31 Mar 22 | 2 | -9 | 5 | 0 |
| 31 Dec 21 | 2 | -9 | 5 | 0 |
| 30 Sep 21 | 2 | -3 | 4 | 0 |
| 30 Jun 21 | 1 | -2 | 5 | 0 |
| 31 Mar 21 | 1 | -3 | 4 | 0 |
| 31 Dec 20 | 0 | -5 | 5 | 0 |
| 30 Sep 20 | 0 | -8 | 6 | 0 |
| 30 Jun 20 | 0 | -9 | 6 | 0 |
| 31 Mar 20 | 0 | -9 | 6 | 0 |
| 31 Dec 19 | 0 | -7 | 5 | 0 |
| 30 Sep 19 | 0 | -7 | 4 | 0 |
| 30 Jun 19 | 0 | -4 | 4 | 0 |
| 31 Mar 19 | 0 | -6 | 6 | 0 |
| 31 Dec 18 | 0 | -6 | 6 | 0 |
| 30 Sep 18 | -2 | -4 | 5 | 0 |
| 30 Jun 18 | -2 | -5 | 4 | 0 |
| 31 Mar 18 | -1 | -1 | 1 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
| 30 Sep 17 | 3 | 1 | 0 | 0 |
| 30 Jun 17 | 2 | 0 | 0 | 0 |
| 31 Mar 17 | 2 | 0 | 0 | 0 |
| 31 Dec 16 | 2 | 0 | 0 | 0 |
| 30 Sep 16 | 2 | -1 | 1 | 0 |
| 30 Jun 16 | 2 | -2 | 1 | 0 |
| 31 Mar 16 | 3 | -2 | 1 | 0 |
| 31 Dec 15 | 3 | -3 | 1 | 0 |
Kaliteli Kazançlar: SUGR.H is currently unprofitable.
Büyüyen Kar Marjı: SUGR.H is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SUGR.H is unprofitable, and losses have increased over the past 5 years at a rate of 25.6% per year.
Büyüme Hızlandırma: Unable to compare SUGR.H's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: SUGR.H is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).
Özkaynak Getirisi
Yüksek ROE: SUGR.H has a negative Return on Equity (-157.95%), as it is currently unprofitable.